Literature DB >> 10448906

Oxidative stress in Systemic Sclerosis.

G Simonini1, M M Cerinic, S Generini, M Zoppi, M Anichini, C Cesaretti, A Pignone, F Falcini, T Lotti, M Cagnoni.   

Abstract

In 63 patients affected by Systemic Sclerosis (SSc) (limited subset: 40; diffuse subset: 23; early: 30; advanced: 33) the peroxidation product diene-conjugates (DC) and antibodies against oxidised low density lipoproteins (Ab oxLDL) were tested in serum by a spectrophotometer (absorbance 234 mn) and by a standard ELISA respectively. The data were compared with those obtained by 21 healthy subjects. DC was significantly higher in patients (73.3 +/- 37.2 microM/l; p < 0.0001) than in controls (48.4 +/- 16.7) as well as in the limited (80 +/- 48.8; p < 0.05) than in the diffuse subset (64.5 +/- 36.4); and in early (84.1 +/- 31.4; p < 0.05) than in advanced stage of the disease (67.9 +/- 42.5). The levels of Ab oxLDL were significantly higher in SSc patients (309.5 +/- 367.2 mU/ml; p < 0.0001) in all its subsets (limited: 351.9 +/- 351.1, p < 0.0001; diffuse: 207.7 +/- 316.1, p < 0.05; early: 428.9 +/- 417.1, p < 0.001; advanced: 302.7 +/- 89.9, p < 0.0001) than in controls (89.3 +/- 29.1). These antibodies levels were higher in limited subset than in diffuse (p < 0.05) and in early SSc than in advanced SSc (p < 0.05). The highest values of parameters of oxidative stress are found in the early stages, when the episodes of reperfusion after ischemic episodes (Raynaud's phenomenon) are very frequent. Moreover, the damage is higher in the early stages of SSc, with intact microvessels, than in late stages, when microvessels are very reduced in number, destroyed by the worsening of the disease. These data show that the respiratory burst deduced by the lipoperoxidation is higher in SSc than in controls, and may be an important pathogenetic factors involved in tissue changes in SSc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10448906

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  48 in total

1.  Extent of oxidative modification of low density lipoprotein determines the degree of cytotoxicity to human coronary artery cells.

Authors:  S A Thorne; S E Abbot; P G Winyard; D R Blake; P G Mills
Journal:  Heart       Date:  1996-01       Impact factor: 5.994

2.  Modified low density lipoprotein is a potent stimulus for smooth muscle cell outgrowth from rat aortic explant in vitro.

Authors:  P Görög
Journal:  Atherosclerosis       Date:  1997-02-28       Impact factor: 5.162

3.  Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma.

Authors:  C M Stein; S B Tanner; J A Awad; L J Roberts; J D Morrow
Journal:  Arthritis Rheum       Date:  1996-07

Review 4.  Low-density lipoprotein and oxidised low-density lipoprotein: their role in the development of atherosclerosis.

Authors:  C A Hamilton
Journal:  Pharmacol Ther       Date:  1997       Impact factor: 12.310

Review 5.  Reactive oxygen species, chromosome mutation, and cancer: possible role of clastogenic factors in carcinogenesis.

Authors:  I Emerit
Journal:  Free Radic Biol Med       Date:  1994-01       Impact factor: 7.376

6.  Human vascular smooth muscle cells and endothelial cells lack catalase activity and are susceptible to hydrogen peroxide.

Authors:  M Shingu; K Yoshioka; M Nobunaga; K Yoshida
Journal:  Inflammation       Date:  1985-09       Impact factor: 4.092

7.  Mechanisms of endothelial cell damage in systemic sclerosis and Raynaud's phenomenon.

Authors:  A D Blann; K Illingworth; M I Jayson
Journal:  J Rheumatol       Date:  1993-08       Impact factor: 4.666

8.  Protective factors against oxygen free radicals and hydrogen peroxide in rheumatoid arthritis synovial fluid.

Authors:  P Biemond; A J Swaak; J F Koster
Journal:  Arthritis Rheum       Date:  1984-07

Review 9.  Involvement of lipoproteins, free radicals, and calcium in cardiovascular disease processes.

Authors:  H Massaeli; G N Pierce
Journal:  Cardiovasc Res       Date:  1995-05       Impact factor: 10.787

10.  Ischemia-induced vascular changes: role of xanthine oxidase and hydroxyl radicals.

Authors:  D A Parks; D N Granger
Journal:  Am J Physiol       Date:  1983-08
View more
  15 in total

1.  The oxidant-antioxidant balance in systemic sclerosis cases with interstitial lung involvement.

Authors:  Benan Musellim; Hande Ikitimur; Hafize Uzun; Gul Ongen
Journal:  Rheumatol Int       Date:  2006-09-02       Impact factor: 2.631

2.  Antioxidant status after iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis.

Authors:  Alexandra Balbir-Gurman; Yolanda Braun-Moscovici; Vladimir Livshitz; Daniel Schapira; Doron Markovits; Alexander Rozin; Tatiana Boikaner; A Menahem Nahir
Journal:  Clin Rheumatol       Date:  2007-03-31       Impact factor: 2.980

Review 3.  Atherosclerosis in systemic sclerosis: a systematic review and meta-analysis.

Authors:  Karen Au; Manjit K Singh; Vijay Bodukam; Sangmee Bae; Paul Maranian; Rikke Ogawa; Brennan Spiegel; Maureen McMahon; Bevra Hahn; Dinesh Khanna
Journal:  Arthritis Rheum       Date:  2011-07

Review 4.  Microvascular damage in systemic sclerosis: detection and monitoring with biomarkers.

Authors:  Laura K Hummers
Journal:  Curr Rheumatol Rep       Date:  2006-04       Impact factor: 4.592

5.  Lipid peroxidation and trace elements in systemic sclerosis.

Authors:  Mohammed Tikly; Kalavati Channa; Penny Theodorou; Mairam Gulumian
Journal:  Clin Rheumatol       Date:  2005-10-25       Impact factor: 2.980

Review 6.  Animal models of scleroderma: current state and recent development.

Authors:  Yoshihide Asano; Shinichi Sato
Journal:  Curr Rheumatol Rep       Date:  2013-12       Impact factor: 4.592

7.  Increasing levels of serum antioxidant status, total antioxidant power, in systemic sclerosis.

Authors:  Fumihide Ogawa; Kazuhiro Shimizu; Eiji Muroi; Toshihide Hara; Shinichi Sato
Journal:  Clin Rheumatol       Date:  2011-02-16       Impact factor: 2.980

Review 8.  Atherosclerosis in autoimmune rheumatic diseases-mechanisms and clinical findings.

Authors:  Hasya Zinger; Yaniv Sherer; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2009-08       Impact factor: 8.667

9.  Specific oxidative stress parameters differently correlate with nailfold capillaroscopy changes and organ involvement in systemic sclerosis.

Authors:  Valeria Riccieri; Antonio Spadaro; Leos Fuksa; Omidreza Firuzi; Luciano Saso; Guido Valesini
Journal:  Clin Rheumatol       Date:  2007-10-27       Impact factor: 2.980

Review 10.  Cardiorheumatology: cardiac involvement in systemic rheumatic disease.

Authors:  Megha Prasad; Joerg Hermann; Sherine E Gabriel; Cornelia M Weyand; Sharon Mulvagh; Rekha Mankad; Jae K Oh; Eric L Matteson; Amir Lerman
Journal:  Nat Rev Cardiol       Date:  2014-12-23       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.